Calculation of gravitational pull at surface of distant stars isn’t an easy task and there is a chance for high degree of error. Astronomers from Universities in Canada, Austria, France and Germany have worked on a collaborative project to develop a new technique for estimating gravity at distant stars. The gravitational pull is an important factor in ascertaining the possibility of life on planets orbiting a specific star. The new technique for calculating gravity has been termed as autocorrelation function timescale technique.
On the eve of Christmas season when everyone was enjoying with their family members dining together and doing fun, J. Michael Pearson was struggling for the severe case of pneumonia in hospital. The 56-year-old CEO of the Valeant Pharmaceuticals International Inc., the drugmaker battered by scandals and questions about sales, was being admitted to the hospital on Christmas Day and is currently receiving treatment.
J. Michael Pearson, CEO of Canadian drugmaker Valeant Pharmaceuticals International Inc, was hospitalized during Christmas as he was under treatment for "severe" pneumonia. Valeant spokeswoman Laurie Little confirmed that Pearson was hospitalized on Friday. Little added, "We wish him a speedy recovery and look forward to him returning to work when he is feeling better."
The U.S. Food & Drug Administration (FDA) has finally lifted the lifetime ban on blood donations from bisexual and gay men, who are clinically referred to as ‘men who have sex with men’ (MSM).
The FDA’s new policy replaces the lifetime ban on gay and bisexual male blood donors with a one-year deferral for gay men. It means gay men must be celibate for at least one year for becoming eligible to donate blood.
A Canadian-made laser has taken a big step on its lengthy journey into space. It is going to scan a remote asteroid, with a hope to better understand the solar system’s early history.
The laser, called OLA, has been funded by the Canadian Space Agency, and will make 3-D maps of the asteroid Bennu. The laser belongs to the OSIRIS-Rex project.
Drug manufacturer Valeant Pharmaceutical International has signed a 20-year deal with Walgreens for introducing discount on its medicines. The move is being seen as an attempt by Valeant to restore its reputation and provide the much-needed boost for its stock price.
Starting in summer 2016, consumers would be able to buy some of the company’s over-the-counter drugs at discounts of up to 95%. The cheaper drugs would mainly be in the fields of dermatology and ophthalmology.